Developments in the screening for Chlamydia trachomatis: A review

Obstetrics and Gynecology Clinics of North America

Volumn 30, Issue 4, 2003, Pages 637-658

  Kohl, Katrin S ^a   Markowitz, Lauri E ^b   Koumans, Emilia H ^b  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TRANSMISSION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ECONOMIC EVALUATION; ELECTROIMMUNOASSAY; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HIGH RISK POPULATION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; LIGASE CHAIN REACTION; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK FACTOR; SCREENING TEST; SERODIAGNOSIS; SEXUAL BEHAVIOR;

EID: 0346992220     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8545(03)00076-7     Document Type: Review

References (116)

1. Centers for Disease Control. Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993. MMWR Morb Mortal Wkly Rep 1993;42(RR-12):1-39.
2. Centers for Disease Control. Sexually transmitted disease surveillance 2001: Division of STD Prevention. Atlanta, GA: US Department of Health and Human Services; 2002.
3. Groseclose SL, Zaidi AA, DeLisle SJ, et al. Estimated incidence and prevalence of genital Chlamydia trachomatis infections in the United States, 1996. Sex Transm Dis 1999;26:339-44.
4. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2001 (supplement): chlamydia prevalence monitoring project, annual report. Atlanta, GA: Department of Health and Human Services; 2001.
5. Washington AE, Johnson RE, Sanders Jr LL. Chlamydia trachomatis infections in the United States. What are they costing us? JAMA 1987;257:85-93.
6. rd edition. New York: McGraw-Hill; 1999. p. 407-22.
7. Golden MR, Schillinger JA, Markowitz L, et al. Duration of untreated genital infections with Chlamydia trachomatis: a review of the literature. Sex Transm Dis 2000;27(6):329-37.
8. Cohen CR, Plummer FA, Mugo N, ct al. Increased interleukin-10 in the endocervical secretion of women with non-ulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission? AIDS 1999;13:327-32.
9. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999;75:3-17.
10. Wasserheit JN. Epidemiological synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992;19:61-77.
11. Foglia G, Rhodes P, Goldberg M, St Louis ME. Completeness of and duration of time before treatment after screening women for Chlamydia trachomatis infections. Sex Transm Dis 1999; 26:421-5.
12. Addiss DG, Vaughn ML, Ludka D, Pfister J, Davis JP. Decreased prevalence of Chlamydia trachomatis infection associated with a selective program in family planning clinics in Wisconsin. Sex Transm Dis 1993;20:28-35.
13. Mertz KJ, Levine WC, Mosure DJ, Berman SM, Dorian KJ. Trends in the prevalence of chlamydial infections: the impact of community-wide testing. Sex Transm Dis 1997;24:169-75.
14. Katz BP, Blythe MJ, Van der Pol B, Jones RB. Declining prevalence of chlamydial infection among adolescent girls. Sex Transm Dis 1996;23:226-9.
15. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996;334: 1362-6.
16. Paavonen J. Pelvic inflammatory disease: from diagnosis to prevention. Dermatol Clin 1998;16: 747-56.
17. Black CM, Marrazzo J, Johnson RE, Hook III EW, Jones RB, Green TA, et al. Head-to-head multicenter comparison of DNA probe and nucleic acid amplification tests for Chlamydia trachomatis infection in women performed with an improved reference standard. J Clin Microbiol 2002;40(10):3757-63.
18. Centers for Disease Control and Prevention. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections 2002. MMWR Morb Mortal Wkly Rep 2002;51(RR-15): 7-8.
19. Chernesky MA, Lee H, Schachter J, Burczak JD, Stamm WE, McCormack WM, et al. Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in a ligase chain reaction assay. J Infect Dis 1994;170:1308-11.
20. Bauwens JE, Clark AM, Loeffelholz MJ, Herman SA, Stamm WE. Diagnosis of Chlamydia trachomatis urethritis in men by polymerase chain reaction assay of first-catch urine. J Clin Microbiol 1993;31:3013-6.
21. Jaschek G, Gaydos CA, Welsh LE, Quinn TC. Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay. J Clin Microbiol 1993;31:1209-12.
22. Chernesky MA, Chong S, Jang D, Luinstra K, Sellors J, Mahony JB. Ability of commercial ligase chain reaction and PCR assays to diagnose Chlamydia trachomatis infections in men by testing first-void urine. J Clin Microbiol 1997;35:982-4.
23. Mahony JB, Luinistra KE, Tyndall M, Sellors JW, Krepel J, Chernesky M. Multiplex PCR for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in genitourinary specimens. J Clin Microbiol 1995;33:3049-53.
24. Carroll KC, Aldeen WE, Morrison M, Anderson R, Lee D, Mottice S. Evaluation of the Abott LCx ligase chain reaction assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine and genital swab specimens from a sexually transmitted disease clinic population. J Clin Microbiol 1998;36:1630-3.
25. Crotchfelt KYA, Welsh LE, DeBonville D, Rosenstraus M, Quinn TC. Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in genitourinary specimens from men and women by a coamplification PCR assay. J Clin Microbiol 1997;35:1536-40.
26. Peeling RW, Toye B, Jessamine P, Gemmill I. Pooling of urine specimens for PCR testing: a cost saving strategy for Chlamydia trachomatis control programmes. Sex Transm Dis 1998;74: 66-70.
27. Krepel J, Patel J, Sproston A, Hopkins F, Jang D, Mahony J, et al. The impact on accuracy and cost of ligase chain reaction testing by pooling urine specimens for the diagnosis of Chlamydia trachomatis infection. Sex Transm Dis 1999;26:504-7.
28. Kacena KA, Quinn SB, Howell MR, Madico GE, Quinn TC, Gaydos CA. Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women. J Clin Microbiol 1998;36:481-5.
29. National Committee for Quality Assurance. HEDIS 2000. The health plan employer data and information set. Volume 1:What's in it and why it matters. Washington, DC: National Committee for Quality Assurance; 2000.
30. Finelli L, Nakashima AK, Hillis S, Crayne E, Spitalny KC. Selective screening versus presumptive treatment criteria for identification of women with chlamydial infection in public clinics in New Jersey. Am J Obstet Gynecol 1996;174:1527-33.
31. Weinstock HS, Bolan GA, Kohn R, Balladares C, Back A, Oliva G. Chlamydia trachomatis infection in women: a need for universal screening in high prevalence populations? Am J Epidemiol 1992;135:41-7.
32. Marrazzo JM, Celum CL, Hillis SD, Fine D, DeLisle S, Handsficld HH. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women: implications for a national Chlamydia control strategy. Sex Transm Dis 1997;24:131-41.
33. Marrazzo JM, Fine D, Celum CL, DeLisle S, Handsfield HH. Selective screening for chlamydial infection in women: a comparison of three sets of criteria. Fam Plann Perspect 1997;29:158-62.
34. Han Y, Coles FB, Hipp S. Screening criteria for Chlamydia trachomatis in family planning clinics: accounting for prevalence and clients' characteristics. Fam Plann Perspect 1997;29: 163-6.
35. Hilger TM, Smith EM, Ault K. Predictors of Chlamydia trachomatis infection among women attending rural Midwest family planning clinics. Infect Dis Obstet Gynecol 2001;9:3-8.
36. Burstein GR, Gaydos CA, Diener-West M, Howell MR, Zenilman JM, Quinn TC. Incident Chlamydia trachomatis infections among inner-city adolescent females. JAMA 1998;12: 521-6.
37. Burstein GR, Waterfield G, Joffe A, Zenilman JM, Quinn TC, Gaydos CA. Screening for gonorrhea and chlamydia by DNA amplification in adolescents attending middle school health centers. Sex Transm Dis 1998;25(8):395-402.
38. Cook RL, St George K, Lassak M, Tran N, Anhalt JP, Rinaldo CR. Screening for Chlamydia trachomatis infection in college women with a polymerase chain reaction assay. Clin Infect Dis 1999;28:1002-7.
39. Mosure DJ, Berman S, Kleinbaum D, Halloran ME. Predictors of Chlamydia trachomatis infection among female adolescents: a longitudinal analysis. Am J Epidemiol 1996;144: 997-1003.
40. Mosure DJ, Berman S, Fine D, DeLisle S, Cates Jr W, Boring III JR. Genital chlamydia infections in sexually active female adolescents: do we really need to screen everyone? J Adolesc Health 1997;20:6-13.
41. Marrazzo JM, Handsfield HH, Whittington WL. Predicting chlamydial and gonococcal cervical infection: implications for management of cervicitis. Obstetrics & Gynecology 2002;100(3): 579-84.
42. Rietmeijer CA, Van Bemmelen R, Judson FN, Douglas Jr JM. Incidence and repeat infection rates of Chlamydia trachomatis among male and female patients in an STD clinic: implications for screening and rescreening. Sexually Transmitted Diseases 2002;20(2):65-72.
43. Orr DP, Johnston K, Brizendine E, Katz B, Fortenberry JD. Subsequent sexually transmitted infection in urban adolescents and young adults. Archives of Pediatrics & Adolescent Medicine 2001;155(8):947-53.
44. Hillis SD, Owens LM, Marchbanks PA, Amsterdam LF, Mac Kenzie WR. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol 1997;176:103-7.
45. Stergachis A, Scholes D, Heidrich FE, Sherer DM, Holmes KK, Stamm WE. Selective screening for Chlamydia trachomatis infection in a primary care population of women. Am J Epidemiol 1993;138:143-53.
46. Magder LS, Harrison RH, Ehret JM, Anderson TS, Judson FN. Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic. Am J Epidemiol 1988;28:298-308.
47. Miller WC, Hoffman IF, Owen-O'Dowd J, McPherson JT, Privette A, Schmitz JL, et al. Selective screening for chlamydial infection: which criteria to use? Am J Prev Med 2000;18: 115-22.
48. Beck-Sague CM, Farshy CE, Jackson TK, Guillory L, Edelkind D, Bullard JC, et al. Detection of Chlamydia trachomatis cervical infection by urine tests among adolescents clinics. J Adolesc Health 1998;22:197-204.
49. Xu F, Schillinger JA, Markowitz LE, Sternberg MR, Aubin MR, St Louis ME. Repeat Chlamydia trachomatis infection in women: analysis through a surveillance case registry in Washington state, 1993-1998. American Journal of Epidemiology 2000;152(12):1164-70.
50. Ellen JM, Aral SO, Magder LS. Do differences in sexual behaviors account for the racial/ethnic differences in adolescents' self-reported history of a sexually transmitted disease. Sex Transm Dis 1998;25(3):125-9.
51. Aral SO, Hughes JP, Stoner B, Whittington W, Handsfield HH, Anderson RM, et al. Sexual mixing patterns in the spread of gonococcal and chlamydial infections. Am J Public Health 1999;89:825-33.
52. Richey CM, Macaluso M, Hook EW. Determinants of reinfection with Chlamydia trachomatis. Sex Transm Dis 1999;26:4-11.
53. Whittington WLH, Kent C, Kissinger P, Oh MK, Fortenberry JD, Hillis SE, et al. Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study. Sex Transm Dis 2001;28(2):117-23.
54. Michelson KN, Thomas JC, Boyd C, Janssens AH. Chlamydia trachomatis infection in a rural population: the importance of screening men. Int J STD AIDS 1999;10:32-7.
55. Hillis SD, Nakashima A, Marchbanks PA, Addiss DG, Davis JP. Risk factors for recurrent Chlamydia trachomatis infections in women. Am J Obstet Gynecol 1994;170:801-6.
56. Burstein GR, Zenilman JM, Gaydos CA, Diener-West M, Howell MR, Brathwaite W, et al. Predictors of repeat Chlamydia trachomatis infections diagnosed by DNA amplification testing among inner city females. Sex Transm Inf 2001;77:26-32.
57. Brodine SK, Shafer MA, Shaffer RA, Boyer CB, Putnam SD, Wignall FS, et al. Asymptomatic sexually transmitted disease prevalence in four military populations: application of DNA amplification assays for chlamydia and gonorrhea screening. J Infect Dis 1998;178:1202-4.
58. Gaydos CA, Howell MR, Quinn TC, Gaydos JC, McKee Jr KT. Use of ligase chain reaction with urine versus cervical culture for detection of Chlamydia trachomatis in an asymptomatic military population of pregnant and nonpregnant females attending Papanicolaou smear clinics. J Clin Microbiol 1998;36:1300-4.
59. Gaydos CA, Howell MR, Pare B, Clark KL, Ellis DA, Hendrix RM, et al. Chlamydia trachomatis infections in female military recruits. N Engl J Med 1998;339:739-44.
60. Oh MK, Smith KR, O'Cain M, Kilmer D, Johnson J, Hook III EW. Urine-based screening of adolescents in detention to guide treatment for gonococcal and chlamydial infections: translating research into intervention. Arch Pediatr Adolesc Med 1998;152:52-6.
61. Centers for Disease Control. High prevalence of chlamydial and gonococcal infection in women entering jails and juvenile detention centers-Chicago, Birmingham, and San Francisco, 1998. MMWR Morb Mortal Wkly Rep 1999;48:703-96.
62. Cohen DA, Nsuami M, Etame RB, Tropez-Sims S, Abdalian S, Farley TA, et al. A school-based chlamydia control program using DNA amplification technology. Pediatrics 1998;101:E1.
63. Gunn RA, Podschun GD, Fitzgerald S, Hovell MF, Farshy CE, Black CM, et al. Screening high-risk adolescent males for Chlamydia trachomatis infection: obtaining urine specimens in the field. Sex Transm Dis 1998;25:49-52.
64. Rietmeijer CA, Yamaguchi KJ, Ortiz CG, Montstream SA, LeRoux T, Ehret JM, et al. Feasibility and yield of screening urine for Chlamydia trachomatis by polymerase chain reaction among high-risk male youth in field-based and other nonclinic settings: a new strategy for sexually transmitted disease control. Sex Transm Dis 1997;24:429-35.
65. Boyer CB, Shafer MA, Teitle E, Wibbelsman CJ, Seeberg D, Schachter J. Sexually transmitted diseases in a health maintenance organization teen clinic: associations of race, partner's age, and marijuana use. Arch Pediatr Adolesc Med 1999;153:838-44.
66. Hamel MJ, Judson FN, Rietmeijer CA. Screening for Chlamydia trachomatis in anonymous and confidential HIV counseling and testing site: feasibility and prevalence rates. Sex Transm Dis 2001;28(3):153-7.
67. Marrazzo JM, White CL, Krekeler B, Celum CL, Lafferty WE, Stamm WE, et al. Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay. Ann Intern Med 1997;127:706-803.
68. McCright JT, Johnson J, Kent C. A collaborative approach between public and non-profit agencies in San Francisco enhances community-based STD screening [abstract D3]. Presented at the National STD Prevention Conference. Dallas, TX, December 6-9, 1998. p. 133.
69. Todd CS, Haase C, Stoner BP. Emergency department screening for asymptomatic sexually transmitted infections. Am J Public Health 2001;91(3):461-4.
70. Mehta SD, Rothman RE, Kelen GD, Quinn TC, Zenilman JM. Unsuspected gonorrhea and chlamydia in patients of an urban adult emergency department: a critical population for STD control intervention. Sex Transm Dis 2001;28(1):33-9.
71. Brackbill RM, Sternberg MR, Fishbein M. Where do people go for treatment of sexually transmitted diseases? Fam Plann Perspect 1999;31:10-5.
72. St Lawrence JS, Montano DE, Kasprzyk D, Phillips WR, Armstrong K, Leichliter JS. STD screening, testing, case reporting, and clinical and partner notification practices: a national survey of US physicians. Am J Public Health 2002;92(11):1784-8.
73. Hogben M, St Lawrence JS, Kasprzyk D, Montano DE, Counts GW, McCrea DH, et al. Sexually transmitted disease screening by United States obstetricians and gynecologists. Obstet Gynecol 2002;100(4):801-7.
74. Bachmann LH, Richey CM, Waites K, Schwebke JR, Hook III EW. Patterns of Chlamydia trachomatis testing and follow-up at a university hospital medical center. Sex Transm Dis 1999;26:496-9.
75. Yealy DM, Greene TJ, Hobbs GD. Under recognition of cervical Neisseria gonorrhoeae and Chlamydia trachomatis infections in the emergency department. Acad Emerg Med 1997;4: 962-7.
76. Rietmeijer CA, Bull SS, Ortiz CG, Leroux T, Douglas Jr JM. Patterns of general health care and STD services use among high-risk youth in Denver participating in community-based urine chlamydia screening. Sex Transm Dis 1998;25:457-63.
77. Chokephaibulkit K, Patamasucon P, List M, Moore B, Rodriguez H. Genital Chlamydia trachomatis infection in pregnant adolescents in east Tennessee: a 7-year case-control study. J Pediatr Adolesc Gynecol 1997;10:95-100.
78. Allaire AD, Huddleston JF, Graves WL, Nathan L. Initial and repeat screening for Chlamydia trachomatis during pregnancy. Infect Dis Gynecol 1998;6:116-22.
79. th meeting of the International Society for Sexually Transmitted Diseases Research. Denver, CO, July 11-14, 1999. p. 227.
80. Niccolai LM, Ethier KA, Kershaw TS, Lewis JB, Ickovics JR. Pregnant adolescents at risk: sexual behaviors and sexually transmitted disease prevalence. Am J Obstet Gynecol 2003; 188(1):63-70.
81. Oh MK, Cloud GA, Baker SL, Pass MA, Mulchahey K, Pass RF. Chlamydial infection and sexual behavior in young pregnant teenagers. Sex Transm Dis 1993;20:45-50.
82. Shaw E, Roberts D, Connor PD. Prevalence of and risk factors for chlamydia in a rural pregnant population. J Fam Pract 1995;41:257-60.
83. Centers for Disease Control. Sexually transmitted diseases treatment guidelines 2002. MMWR Morb Mortal Wkly Rep 2002;51(RR-6):5.
84. Paavonen J, Puolakkainen M, Paukku M, Sintonen H. Cost-benefit analysis of first-void urine Chlamydia trachomatis screening program. Obstet Gynecol 1998;92:292-8.
85. Shafer MA, Pantell RH, Schachter J. Is the routine pelvic examination needed with the advent of urine-based screening for sexually transmitted diseases? Arch Pediatr Adolesc Med 1999; 153:119-25.
86. Howell MR, Quinn TC, Gaydos CA. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics: a cost-effectiveness analysis of three strategies. Ann Intern Med 1998;128:277-84.
87. Howell MR, Gaydos JC, McKee Jr KT, Quinn TC, Gaydos CA. Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease. Sex Transm Dis 1999;26:519-26.
88. Genc M, Mardh P-A. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med 1996;124:1-7.
89. Howell R, Quinn TC, Brathwaite W, Gaydos CA. Screening women for Chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays. Sex Transm Dis 1998;25:108-17.
90. Quinn TC, Gaydos C, Shepherd M, Bobo L, Hook III EW, Viscidi R, et al. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA 1996; 276:1737-42.
91. Ku L, St Louis M, Farshy C, Aral S, Turner CF, Lindberg LD, et al. Risk behaviors, medical care, and chlamydial infection among young men in the United States. Am J Public Health 2002;92(7): 1140-3.
92. Turner CF, Rogers SM, Miller HG, Miller WC, Gribble JN, Chromy JR, et al. Untreated gonococcal and chlamydial infection in a probability sample of adults. JAMA 2002;287(6):726-33.
93. Burstein GR, Snyder MH, Conley D, Boekeloo BO, Quinn TC, Zenilman JM. Adolescent chlamydia testing practices and diagnosed infections in a large managed care organization. Sex Transm Dis 2001;28(8):477-83.
94. Urban MA, Coury-Doniger P, Reichman RC. Results of a screening program for Chlamydia trachomatis infection in men attending a sexually transmitted diseases clinic. Sex Transm Dis 1997;24:587-92.
95. Pack RP, Diclemente RJ, Hook III EW, Oh MK. High prevalence of asymptomatic STDs in incarcerated minority male youth: a case for screening. Sex Transm Dis 2000;27(3):175-7.
96. Neu N, Grumet S, McNees A, Lai L, Della-Latta P, Whittier S, et al. Screening for Chlamydia trachomatis in young men by ligase chain reaction. Pediatr Infect Dis J 1999;18(7):649-50.
97. Cecil JA, Howell MR, Tawes JJ, Gaydos JC, McKee Jr KT, Quinn TC, et al. Features of Chlamydia trachomatis and Neisseria gonorrhoeae infection in male Army recruits. J Infect Dis 2001;184(9):1216-9.
98. Culler C, Evens A, Anderson S, et al. Screening for chlamydia and gonorrhea in a Chicago high school using urine LCx testing [abstract 405]. Presented at the 13th meeting of the International Society for Sexually Transmitted Diseases Research. Denver, CO, July 11-14, 1999. p. 225.
99. Cohen DA, Nsuami M, Martin DH, Farley TA. Repeated school-based screening for sexually transmitted diseases: a feasible strategy for reaching adolescents. Pediatrics 1999;104(6): 1281-5.
100. Shafer MA, Schachter J, Moncada J, Keogh J, Pantell R, Gourlay L, et al. Evaluation of urine-based screening strategies to detect Chlamydia trachomatis among sexually active asymptomatic young males. JAMA 1993;270:2065-70.
101. Genc M, Ruusuvaara L, Mardh PA. An economic evaluation of screening for Chlamydia trachomatis in adolescent males. JAMA 1993;270:2057-64.
102. Howell MR, Kassler WJ, Haddix A. Partner notification to prevent pelvic inflammatory disease in women: cost-effectiveness of two strategies. Sex Transm Dis 1997;24:287-92.
103. Welte R, Kretzschmar M, Leidl R, van den Hoek A, Jager JC, Postma MJ. Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach. Sex Transm Dis 2000;27(9):518-29.
104. Centers for Disease Control. Sexually transmitted diseases guidelines 2002. MMWR Morb Mortal Wkly Rep 2002;51(RR-6):32.
105. Centers for Disease Control. HIV prevention through early detection and treatment of other sexually transmitted diseases: United States recommendations of the Advisory Committee for HIV and STD Prevention. MMWR Morb Mortal Wkly Rep 1998;47(RR-12):9-10.
106. American Medical Association. Guidelines for adolescent preventive services (GAPS): recommendations and rationale. Chicago: American Medical Association; 1994.
107. Davies HD, Wang EE. Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination. Can Med Assoc J 1996; 154:1631-44.
108. US Preventive Services Task Force. Screening for chlamydial infection: recommendations and rationale. Am J Prev Med 2001;20(3S):90-4.
109. Nelson HD, Helfand M. Screening for chlamydial infection. Am J Prev Med 2001;20(3S): 95-107.
110. th edition. Elk Grove Village (IL): American Academy of Pediatrics; 2000. p. 139.
111. American Academy of Family Physicians. Policy recommendations for periodic health examinations. American Academy of Family Physicians 2002, revision 5.3. Available at: http://www. aafp.org. Accessed September 29, 2003.
112. American College of Obstetricians and Gynecologists. Committee on Primary Care. Primary and preventive care: periodic assessments. American College of Obstetricians and Gynecologists; 1999. p. 229.
113. American College of Obstetricians and Gynecologists. Committee on Gynecological Practice. Primary and Preventive Care: Periodic Assessments. Committee Opinion 2000; No. 246. Washington DC; December 2000. p. 1-9.
114. Thrall JS, McCloskey L, Spivak H, Ettner SL, Tighe JE, Emans SJ. Performance of Massachusetts HMOs in providing Pap smear and sexually transmitted disease screening to adolescent females. J Adolesc Health 1998;22:184-9.
115. Centers for Disease Control and Prevention. Notice of the availability of funds: innovative demonstration projects to screen and treat symptomatic males for Chlamydia trachomatis infection using urine-based diagnostic tests. Translational research. Fed Regist 1999;64:26761-5.
116. Centers for Disease Control and Prevention. Screening optimally for chlamydia: resource allocation, testing and evaluation software. Available at: http://www.cdc.gov/nchstp/dstdp/software/Socrates.htm. Accessed September 29, 2003.